Skip to main content
search

Tom Koglman practices intellectual property law with an emphasis on patent litigation. He has experience in a variety of fields, including chemical compositions, pharmaceuticals, biotechnology, and medical devices.

In 2016, Tom was a member of the trial team that achieved the record-breaking patent infringement verdict for Idenix Pharmaceuticals (a subsidiary of Merck & Co.), the largest infringement verdict in U.S. history. After a two-week trial, the jury ordered Gilead Sciences to pay $2.54 billion in damages for sales of sofosbuvir-based medicines, including Sovaldi and Harvoni, for its infringement of an Idenix patent related to the treatment of patients with hepatitis C virus (HCV) infection.


+1-216-586-1047

Thomas S. Koglman

Associate
Jones Day
Cleveland

Practice Area: Intellectual Property

All-Star

WHAT CLIENTS SAY

"Tom's ability to deeply understand our issues is much appreciated."
"His work is both superior and timely."

MY CLIENT PHILOSOPHY

"Build a partnership of trust and shared goals with clients by listening and always providing honest feedback. Give clients the quality of work, the respect, and the attention you would expect if you were in their position."

– Thomas S. Koglman

ALL-STAR BIOGRAPHY

Tom Koglman practices intellectual property law with an emphasis on patent litigation. He has experience in a variety of fields, including chemical compositions, pharmaceuticals, biotechnology, and medical devices.

In 2016, Tom was a member of the trial team that achieved the record-breaking patent infringement verdict for Idenix Pharmaceuticals (a subsidiary of Merck & Co.), the largest infringement verdict in U.S. history. After a two-week trial, the jury ordered Gilead Sciences to pay $2.54 billion in damages for sales of sofosbuvir-based medicines, including Sovaldi and Harvoni, for its infringement of an Idenix patent related to the treatment of patients with hepatitis C virus (HCV) infection.

Visit All-Star's Firm »


+1-216-586-1047

Thomas S. Koglman

Associate
Jones Day
Cleveland

Practice Area: Intellectual Property

M&A All-Star

ALL-STAR BIOGRAPHY

Tom Koglman practices intellectual property law with an emphasis on patent litigation. He has experience in a variety of fields, including chemical compositions, pharmaceuticals, biotechnology, and medical devices.

In 2016, Tom was a member of the trial team that achieved the record-breaking patent infringement verdict for Idenix Pharmaceuticals (a subsidiary of Merck & Co.), the largest infringement verdict in U.S. history. After a two-week trial, the jury ordered Gilead Sciences to pay $2.54 billion in damages for sales of sofosbuvir-based medicines, including Sovaldi and Harvoni, for its infringement of an Idenix patent related to the treatment of patients with hepatitis C virus (HCV) infection.

Visit All-Star's Firm »